AbbVie Demonstrates Commitment to Hepatitis C Patients with New Data on VIEKIRA PAKâ¢ (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) and Ongoing Clinical Development Program at The Liver MeetingÂ® 2015